280 related articles for article (PubMed ID: 22560389)
1. Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
Nevzorov R; Porath A; Henkin Y; Kobal SL; Jotkowitz A; Novack V
Eur J Intern Med; 2012 Jun; 23(4):374-8. PubMed ID: 22560389
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
Nevzorov R; Novack V; Henkin Y; Kobal SL; Jotkowitz A; Porath A
Eur J Intern Med; 2009 Sep; 20(5):494-8. PubMed ID: 19712852
[TBL] [Abstract][Full Text] [Related]
3. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
4. Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: a propensity-adjusted case-control populational study.
Gomez-Soto FM; Romero SP; Bernal JA; Escobar MA; Puerto JL; Andrey JL; Almenara J; Gomez F
Int J Cardiol; 2011 Jan; 146(1):51-5. PubMed ID: 19573938
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
[TBL] [Abstract][Full Text] [Related]
6. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
[TBL] [Abstract][Full Text] [Related]
8. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
9. Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers.
Anguita M; Castillo JC; Ruiz M; Castillo F; Jiménez-Navarro M; Crespo M; Alonso-Pulpón L; de Teresa E; Castro-Beiras A; Roig E; Artigas R; Zapata A; de Ullibarri IL; Muñiz J;
Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):22-8. PubMed ID: 22001308
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
11. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
12. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
Macín SM; Perna ER; Címbaro Canella JP; Alvarenga P; Pantich R; Ríos N; Farías EF; Badaracco JR
Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Cohn JN; Tognoni G;
N Engl J Med; 2001 Dec; 345(23):1667-75. PubMed ID: 11759645
[TBL] [Abstract][Full Text] [Related]
14. Beta-blocker use and outcomes among hospitalized heart failure patients.
Butler J; Young JB; Abraham WT; Bourge RC; Adams KF; Clare R; O'Connor C;
J Am Coll Cardiol; 2006 Jun; 47(12):2462-9. PubMed ID: 16781374
[TBL] [Abstract][Full Text] [Related]
15. Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction.
Tehrani F; Phan A; Chien CV; Morrissey RP; Rafique AM; Schwarz ER
Am J Cardiol; 2009 Mar; 103(6):829-33. PubMed ID: 19268740
[TBL] [Abstract][Full Text] [Related]
16. Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I.
Komajda M; Hanon O; Hochadel M; Follath F; Swedberg K; Gitt A; Cleland JG
Eur Heart J; 2007 Jun; 28(11):1310-8. PubMed ID: 17185303
[TBL] [Abstract][Full Text] [Related]
17. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
Andersson B; Kjörk E; Brunlöf G
Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
20. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
